Topas Therapeutics
A biotechnology company focused on developing products to address areas of major unmet need.
Topas Therapeutics has raised €40M across 2 funding rounds from 8 investors, most recently a Series B round in Jul 2021. Based in Hamburg, Germany; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€40M
€40,000,000
Funding rounds
2
Investors
8
distinct backers
Active since
2020-10
latest 2021-07
Funding by year
EUR raised per yearTopas Therapeutics — funding by year — interactive chart.
Data table
| Topas Therapeutics — funding by year | |
|---|---|
| 2020 | €22M |
| 2021 | €18M |
Signals
High confidenceRaise-next likelihood8
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (20y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-29 | Series B | €18M | BioMedPartners,Boehringer Ingelheim Venture Fund,EMBL Ventures,Epidarex Capital,Evotec,GIMV+1 more | View deal → |
| 2020-10-19 | Series B | €22M | BioMedPartners,Vesalius Biocapital Partners | View deal → |
Investors
8Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData